Preclinical data reveal ongoing progress of lead assets and discovery platform as the company prepares to enter the clinic in early 2025 BOSTON, Oct. 10, 2024 /PRNewswire/ — Sensorium Therapeutics, a biotechnology company developing novel, first-in-class medicines to treat a variety of…
